Paper42881169PubMed
15-PGDH inhibition in osteoarthritis: PGE2 skeletal interoception, cartilage regeneration and compartment-managed disease modification.
Chen Q and 3 others. Bone Res, 2026.
Cite this record
ConductScience Library. 15-PGDH inhibition in osteoarthritis: PGE2 skeletal interoception, cartilage regeneration and compartment-managed disease modification. Papers, record 42881169. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42881169
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- 15-PGDH inhibition in osteoarthritis: PGE2 skeletal interoception, cartilage regeneration and compartment-managed disease modification.
- Journal
- Bone Res
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-20
Source PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Osteoarthritis | Major topic |
| Dinoprostone | Major topic |
| Hydroxyprostaglandin Dehydrogenases | Major topic |
| Regeneration | Major topic |
| Cartilage | Major topic |
| Bone and Bones | Major topic |
| Humans | |
| Animals |
Source PubMed
References94
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39755397 | Osteoarthritis. | Lancet | 2025 | https://conductscience.org/library/papers/39755397 | PubMed |
| 2 | 40382623 | Beyond symptomatic alignment: evaluating the integration of causal mechanisms in matching animal models with human pathotypes in osteoarthritis research. | Arthritis Res Ther | 2025 | https://conductscience.org/library/papers/40382623 | PubMed |
| 3 | 36198371 | Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations. | J Pain | 2023 | https://conductscience.org/library/papers/36198371 | PubMed |
| 4 | 35256606 | A novel prostaglandin E receptor 4 (EP4) small molecule antagonist induces articular cartilage regeneration. | Cell Discov | 2022 | https://conductscience.org/library/papers/35256606 | PubMed |
| 5 | 40662950 | Opposing regulation of TNF responses by IFN-γ and a PGE2-cAMP axis that is apparent in rheumatoid and immune checkpoint inhibitor-induced arthritis human IL-1β+ macrophages. | Elife | 2025 | https://conductscience.org/library/papers/40662950 | PubMed |
| 6 | 38561376 | Skeletal interoception in osteoarthritis. | Bone Res | 2024 | https://conductscience.org/library/papers/38561376 | PubMed |
| 7 | 40138204 | Hypothalamus Regulates Anabolic Metabolism of Articular Cartilage Superficial Chondrocytes through PGE2 Skeletal Interoception. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40138204 | PubMed |
| 8 | 40796685 | Peripheral neuronal sensitization and neurovascular remodelling in osteoarthritis pain. | Nat Rev Rheumatol | 2025 | https://conductscience.org/library/papers/40796685 | PubMed |
| 9 | 39910066 | Neurovascularization inhibiting dual responsive hydrogel for alleviating the progression of osteoarthritis. | Nat Commun | 2025 | https://conductscience.org/library/papers/39910066 | PubMed |
| 10 | 39476339 | Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. | N Engl J Med | 2024 | https://conductscience.org/library/papers/39476339 | PubMed |
| 11 | 38311627 | Spatial analysis of the osteoarthritis microenvironment: techniques, insights, and applications. | Bone Res | 2024 | https://conductscience.org/library/papers/38311627 | PubMed |
| 12 | 41418993 | Osteoarthritis year in review 2025: Biology. | Osteoarthritis Cartilage | 2026 | https://conductscience.org/library/papers/41418993 | PubMed |
| 13 | 38262526 | Revisiting prostaglandin E2: A promising therapeutic target for osteoarthritis. | Clin Immunol | 2024 | https://conductscience.org/library/papers/38262526 | PubMed |
| 14 | 38658748 | PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells. | Nature | 2024 | https://conductscience.org/library/papers/38658748 | PubMed |
| 15 | 40164779 | The causal role of brain circuits in osteoarthritis pain. | Nat Rev Rheumatol | 2025 | https://conductscience.org/library/papers/40164779 | PubMed |
| 16 | 40753276 | A multi-tissue human knee single-cell atlas identifies that osteoarthritis reduces regenerative tissue stem cells while increasing inflammatory pain macrophages. | Commun Biol | 2025 | https://conductscience.org/library/papers/40753276 | PubMed |
| 17 | 38740860 | Recent advancements in cartilage tissue engineering innovation and translation. | Nat Rev Rheumatol | 2024 | https://conductscience.org/library/papers/38740860 | PubMed |
| 18 | 31666999 | Inhibition of cyclooxygenase-2 activity in subchondral bone modifies a subtype of osteoarthritis. | Bone Res | 2019 | https://conductscience.org/library/papers/31666999 | PubMed |
| 19 | 36696492 | A "best-in-class" systemic biomarker predictor of clinically relevant knee osteoarthritis structural and pain progression. | Sci Adv | 2023 | https://conductscience.org/library/papers/36696492 | PubMed |
| 20 | 40885756 | Structure and transport mechanism of the human prostaglandin transporter SLCO2A1. | Nat Commun | 2025 | https://conductscience.org/library/papers/40885756 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42881169
GET https://conductscience.org/api/papers/v1/42881169/references?page=2